IFC Holdings’s Invesco Pharmaceuticals ETF PJP Stock Holding History

IFC Holdings’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-3,145	Closed	-$220K	–	402
2015 Q4	$220K	Sell	3,145 -808	-20%	-$57.3K	0.03%	327
2015 Q3	$278K	Sell	3,953 -166	-4%	-$12.9K	0.04%	280
2015 Q2	$327K	Buy	4,119 +637	+18%	+$49.6K	0.05%	274
2015 Q1	$269K	Buy	+3,482	New	+$256K	0.04%	295

Other funds holding PJP

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

NFC

Northeast Financial Consultants Westport, Connecticut $2.45B AUM 15.14% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

PAM

Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

SCM

Summit Capital Management Seattle, Washington $221M AUM 4.14% 1-Year Est. Return

IFC Holdings's PJP Position: Q1 2016 in Review

IFC Holdings sold out of Invesco Pharmaceuticals ETF (PJP) in Q1 2016, closing a stake of 3,145 shares — an estimated $220K sold.

IFC Holdings first reported a position in PJP in Q1 2015 and held it in 4 quarters. The position peaked at $327K in Q2 2015. 93 funds tracked by Wall St. Rank hold PJP as of Q1 2016.

IFC Holdings reported no remaining Invesco Pharmaceuticals ETF position as of Q1 2016 after selling out during the quarter.
IFC Holdings sold 3,145 Invesco Pharmaceuticals ETF shares in Q1 2016, an estimated $220K.
IFC Holdings first reported a position in Invesco Pharmaceuticals ETF in Q1 2015 and held it in 4 quarters.
IFC Holdings's Invesco Pharmaceuticals ETF position peaked at $327K in Q2 2015.
93 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q1 2016.

Based on IFC Holdings's 13F filing for Q1 2016, filed 5 May 2016.